Cost-minimization Analysis of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients With Primary Immunodeficiency
Keywords: cost minimization; home-based therapy; immunoglobulin replacement therapy; pharmacoeconomics; productivity loss; subcutaneous IgG;